Leptomeningeal metastases in the MRI era
- 4 May 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 74 (18), 1449-1454
- https://doi.org/10.1212/wnl.0b013e3181dc1a69
Abstract
Background: Diagnosis of leptomeningeal metastasis (LM) has become increasingly frequent. The diagnostic gold standard has been CSF cytology, but MRI is now used routinely for diagnosis. Diagnosis and prognosis of LM has not been studied in the MRI era. Methods: Patients with LM from 2002 through 2004 were identified through a neurology database, as well as by reviewing all abnormal CSF cytologies from a pathology database. Diagnosis was made by malignant cytology or imaging; suspicious cases treated as LM were also included. Results: A total of 187 patients with LM were analyzed in this retrospective review. Of these, 150 had solid and 37 had hematopoietic malignancies. Median age was 56.4 years, and median Karnofsky performance status (KPS) was 70. The most common types of solid tumor were breast (65 patients), lung (47), gastrointestinal (11), and melanoma (9). Of the hematopoietic tumors, 21 were lymphoma and 15 were leukemia. Fifty-three percent of patients were diagnosed by imaging, 23% by cytology, and 24% by both. Treatment included radiation therapy in 55%, intrathecal chemotherapy in 29%, and systemic chemotherapy in 18%; 21% received supportive care alone. Median overall survival was 2.4 (95% confidence interval 1.9–3.1) months. Median survival for patients with hematopoietic tumors was 4.7 months and for solid tumors was 2.3 months (p = 0.0006). In multivariate analysis, initial KPS and tumor type (solid vs hematopoietic) were significant predictors of survival. Conclusions: Despite enhanced diagnosis with MRI, prognosis remains poor in leptomeningeal metastasis. Those with hematopoietic tumors continue to fare better than those with solid tumors.Keywords
This publication has 15 references indexed in Scilit:
- Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumorsJournal of Neuro-Oncology, 2008
- Ventriculoperitoneal shunt in patients with leptomeningeal metastasisNeurology, 2005
- Leptomeningeal metastasis: survival and prognostic factors in 155 patientsJournal of the Neurological Sciences, 2004
- Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastasesJournal of Neurosurgery, 1997
- Leptomeningeal CarcinomatosisArchives of Neurology, 1996
- Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasisAnnals of Neurology, 1995
- Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemiasJournal of Neuro-Oncology, 1990
- Ommaya reservoirs in 387 cancer patientsNeurology, 1985
- Diffuse involvement of the leptomeninges by tumour--a clinical and pathological study of 63 casesPostgraduate Medical Journal, 1980
- Infiltration of the Leptomeninges by Systemic CancerArchives of Neurology, 1974